Search
Close this search box.

SBRT as a Salvage Option for Localized Recurrent Prostate Cancer

April 17, 2019

Donald Fuller, M.D.
Genesis Healthcare Partners – San Diego, CA

Donald B. Fuller, M.D. has been practicing medicine since 1988. He enjoys maximizing the power of technology against cancer by staying at the leading edge of technology innovation, and believes in putting new treatments into practice as soon as they become available.

His interests in the specialty include prostate cancer radiotherapy, prostate CyberKnife Stereotactic Body Radiotherapy (SBRT), and radiation dose escalation for a variety of malignancies through the appropriate application of intensity modulated radiotherapy (IMRT) and stereotactic (SBRT) techniques.

Dr. Fuller is the national principal investigator of a multi-institutional prostate CyberKnife clinical trial. He also has published an original CT-ultrasound fusion prostate brachytherapy technique, as well as original manuscripts in the areas of lung cancer, pediatric cancer, sarcoma and gynecologic oncology. He is currently a reviewer for several peer-reviewed medical journals, including the International Journal of Radiation Oncology, Biology and Physics, and Brachytherapy.

When he is not working, Dr. Fuller enjoys a variety of activities, including hiking, running, physical fitness training, an eclectic menu of reading interests and watching competitive sports.